There is no proven cure for the coronavirus pandemic going up every facet of life, but now a second study shows that plasma from recovered COVID-19 patients injected into critically ill patients can help.
The study stresses the “effectiveness” of convalescent plasma therapy in patients with serious cases of COVID-19. The new research, performed by doctors in Wuhan, China, the outbreak’s epicenter, gave infusions of 200 milliliters of convalescent plasma to 10 patients and found their conditions improved.
Results from 10 extreme adult cases showed that one dose (200 mL) of [convalescent plasma] was well tolerated and could substantially increase or sustain high-level neutralizing antibodies, leading to the disappearance of [convalescent plasma] in 7 [days].”
“In the meantime, clinical signs and paraclinical requirements improved rapidly within 3 [days]. Varying degrees of absorption within 7 [days] of lung lesions. These results indicate that CP can serve as a promising rescue alternative for extreme COVID-19 while warranting the randomized study.
STUDY SUGGESTS BLOOD OF RECOVERED CORONAVIRUS PATIENTS BE USED TO Support ‘CRITICALLY ILL PATIENTS’
According to an article published last month in the medical journal The Lancet, harnessing the blood plasma of recovered patients is known as “convalescent plasma,” which was used in fighting the SARs outbreak.
None of the patients died and even more importantly there were “no significant adverse effects” reported, the researchers noted.
Although the early findings are promising, researchers are quick to warn that other considerations, such as the “optimal dosage and timing level, as well as the clinical benefit of CP therapy, need further study in larger well-controlled trials.”
The thesis was published in the National Academy of Sciences Proceedings.
The Wuhan-based study comes on five other patients who have been considered “critically ill” following a previous report by doctors in Shenzen, China. Doctors found that giving them an experimental plasma transfusion containing a “neutralizing antibody” aided in their recovery.
A Houston-area hospital became the first facility in the US to transfuse a revived COVID-19 patient’s blood plasma into one that was critically ill on March 29.
The state of New York has recently revealed it will use the blood plasma of treated patients to combat the pandemic. A Mount Sinai spokesperson recently told Fox News that on the evening of March 29, the hospital had launched its plasma convalescence program.
The spokespersons added on Wednesday that it will “probably be another 2-3 weeks until we have enough preliminary data to provide an estimate as to what the importance of the research treatment
Since receiving approval from the Food and Drug Administration, other hospitals around the country are now conducting the experimental study.
More than 1,44 million cases of coronavirus had been diagnosed worldwide as of Wednesday morning, including more than 399,000 in the U.S., the world’s most affected country.
Your email address will not be published. Required fields are marked *